The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines

Clicks: 353
ID: 100751
2020
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #3 of 10 articles by views in NPJ vaccines

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The outbreak of 2019-novel coronavirus disease (COVID-19) that is caused by SARS-CoV-2 has spread rapidly in China, and has developed to be a Public Health Emergency of International Concern. However, no specific antiviral treatments or vaccines are available yet. This work aims to share strategies and candidate antigens to develop safe and effective vaccines against SARS-CoV-2.
Reference Key
shang2020thenpj Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Shang, Weilong;Yang, Yi;Rao, Yifan;Rao, Xiancai;
Journal NPJ vaccines
Year 2020
DOI
10.1038/s41541-020-0170-0
URL
http://link.springer.com/article/10.1038/s41541-020-0170-0
Keywords
Infectious and parasitic diseases Medicine (General) Medicine Medical emergencies. Critical care. Intensive care. First aid Immunologic diseases. Allergy general works neoplasms. tumors. oncology. including cancer and carcinogens public aspects of medicine naval science

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.